Astec LifeSciences Limited has clarified that it has disclosed all necessary information impacting share prices to the stock exchanges as required.

Addressing a recent significant increase in trading volume, the company has confirmed that no undisclosed events or pending developments exist that require mandatory disclosure.

Management assures shareholders that the company remains fully compliant with all disclosure obligations and will continue to share relevant operational updates transparently as required.